Cytogenetic damage as a biomarker of radiation sensitivity in prostate cancer,
Role: Co-Investigator,
Columbia University,
(08/2014 - 07/2015)
Status: Closed
Federal
Radiation Medicine Central Nervous System Studies Phase II,
Role: Co-PD/PI,
Department of Defense,
(09/2011 - 09/2016)
Status: Closed
Translating Proton CT from the Physics Laboratory to Clinical Application,
Role: Co-Investigator,
National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS,
(04/2011 - 01/2016)
Status: Closed
Radiation Medicine Central Nervous System Studies,
Role: Co-PD/PI,
Department of Defense,
(09/2010 - 10/2012)
Status: Closed
Study to Measure Biologic Effects by Proton Scanning Techniques,
Role: Co-PD/PI,
Department of Defense,
(09/2007 - 12/2012)
Status: Closed
Foreign
Multidisciplinary Evaluation of the Cancer Risk from Neutrons Relative to Photons,
Role: Co-Investigator,
European Commission,
(03/2012 - 12/2015)
Status: Closed
Internal
Phase I-II trial of stereotactic body proton therapy for patients with liver metastases,
Role: Investigator,
LLU Dept. of Radiation Medicine,
(08/2024 - 08/2025)
Status: Approved
Proton vs. IMRT planning study for radiosurgery of brain metastasis,
Role: PI,
LLU Dept. of Radiation Medicine,
(05/2015)
Status: Completed